Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 and up

Intrapleural ropivacaine after heart surgery

Official title: Intrapleural Ropivacaine Infusion in Cardiac Surgery: Randomized Double-blind Controlled Study

Run by Saint Petersburg State University, Russia · NCT07116343 · Data updated 2026-11-12

This study will test whether putting ropivacaine into the pleural space through chest drains reduces pain and improves recovery for adults after heart surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment116 (estimated)
SponsorSaint Petersburg State University, Russia
Academic / other
Locations2 sites (Saint Petersburg and 1 other locations)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedSeptember 25, 2027
Study endsDecember 1, 2027
Registry record updatedMarch 10, 2026
Trial IDNCT07116343 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) scheduled for cardiac surgery via median sternotomy with planned pleural opening who can give informed consent and have no contraindication to ropivacaine are ideal candidates.

Probably not a fit

Patients who are undergoing redo cardiac surgery, those with contraindications to ropivacaine, or patients who do not have pleural drains are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, placebo-controlled Phase 4 trial comparing intrapleural ropivacaine infusion to saline in adults having cardiac surgery with planned opening of the pleural cavities. After median sternotomy and placement of pleural drains, participants receive either ropivacaine or 0.9% NaCl through the drains for the early postoperative period. Outcomes include postoperative pain, opioid consumption, quality of recovery, and safety/complications related to the local anesthetic. The trial is conducted at university and regional hospital sites in Russia.

Why it matters

Potential benefit: If successful, patients could experience less chest pain, lower opioid needs, and a faster recovery after heart surgery.

How similar studies have gone: Prior intrapleural anesthetic use after thoracic surgery has shown safety and reduced pain, though evidence specifically in cardiac surgery is more limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled cardiac surgery using a standard median sternotomy.
* Planned opening of the pleural cavities.
* Age more than 18 years.
* Signed informed consent to participate in the study.

Exclusion Criteria:

* Contraindications for ropivacaine
* Redo surgery

Where it's running

  • Saint-Petersburg university hospital
    Saint Petersburg, Russia
    Recruiting
  • Primorskiy general hospital #1
    Vladivostok, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.